Biomemory

Biomemory

Private
ParisAI, Data & Cloud Infrastructurehttps://biomemory.com

Last Round

Grant

Mar 4, 2026

Total Funding Raised

$23.2M

Company Overview

Biomemory is a biotechnology company developing DNA-based data storage solutions designed to be sustainable and high-density.

Sector

AI, Data & Cloud Infrastructure

Verticals

Data Warehousing, Cloud Infrastructure, Computing Hardware, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

DNA data storageDNA storagearchival storagecold storagesynthetic DNAhigh-density storagesustainable data storagestorage appliancedata center storagemolecular data storageDNA encodingsynthetic biologyDNA synthesisdeep-techDNA card

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biomemory Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Biomemory Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMar 4, 2026
Series ADec 10, 2024
SeedNov 28, 2022

Key People

Founding team and executive leadership

Chrystelle Roger

Strategic Advisor To The CEO

Executive Team

Lionel ARNAUD

Chief Operating Officer

Executive Team

Biomemory Investors

Notable investors and investment history

InvestorRounds
Blast.clubSeries A
BpifranceSeries A
Paris Business AngelsSeed, Series A
ADNEXUSSeries A
Crédit Mutuel InnovationSeries A
Groupe PrunaySeries A
Next SequenceSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2026

    New entity established for R&D, production, and customer support.

  • Mar 4, 2026

    Received grant funding to support operations.

Biomemory Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biomemory Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biomemory's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range73
Year Founded2021
Last FundingMar 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.